Correction: Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus-unrelated Head and Neck Cancer: A Multicenter, Phase II Trial

Clin Cancer Res. 2021 Jan 1;27(1):357. doi: 10.1158/1078-0432.CCR-20-4484.
No abstract available

Publication types

  • Published Erratum